References
1. Shawon MS, Perret JL, Senaratna CV, Lodge C, Hamilton GS, Dharmage SC. Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: A systematic review. Sleep Med Rev. 2017;32:58-68.
2. Kong DL, Qin Z, Shen H, Jin HY, Wang W, Wang ZF. Association of Obstructive Sleep Apnea with Asthma: A Meta-Analysis. Sci Rep.2017;7(1):4088.
3. Teodorescu M, Barnet JH, Hagen EW, Palta M, Young TB, Peppard PE. Association between asthma and risk of developing obstructive sleep apnea. JAMA. 2015;313(2):156-164.
4. Soler X, Gaio E, Powell FL, et al. High Prevalence of Obstructive Sleep Apnea in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2015;12(8):1219-1225.
5. Perin C, Fagondes SC, Casarotto FC, Pinotti AF, Menna Barreto SS, Dalcin Pde T. Sleep findings and predictors of sleep desaturation in adult cystic fibrosis patients. Sleep Breath.2012;16(4):1041-1048.
6. Milross MA, Piper AJ, Dobbin CJ, Bye PT, Grunstein RR. Sleep disordered breathing in cystic fibrosis. Sleep Med Rev.2004;8(4):295-308.
7. McNicholas WT, Hansson D, Schiza S, Grote L. Sleep in chronic respiratory disease: COPD and hypoventilation disorders. Eur Respir Rev. 2019;28(153).
8. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd Edition. Darien, IL: American Academy of Sleep Medicine, 2014.
9. Mohammadieh A, Sutherland K, Cistulli PA. Sleep disordered breathing: management update. Intern Med J. 2017;47(11):1241-1247.
10. Akerstedt T, Ghilotti F, Grotta A, Bellavia A, Lagerros YT, Bellocco R. Sleep duration, mortality and the influence of age. Eur J Epidemiol. 2017;32(10):881-891.
11. Naqvi SK, Sotelo C, Murry L, Simakajornboon N. Sleep architecture in children and adolescents with cystic fibrosis and the association with severity of lung disease. Sleep Breath. 2008;12(1):77-83.
12. Bradley S, Solin P, Wilson J, Johns D, Walters EH, Naughton MT. Hypoxemia and hypercapnia during exercise and sleep in patients with cystic fibrosis. Chest. 1999;116(3):647-654.
13. Spicuzza L, Sciuto C, Leonardi S, La Rosa M. Early occurrence of obstructive sleep apnea in infants and children with cystic fibrosis.Arch Pediatr Adolesc Med. 2012;166(12):1165-1169.
14. Bandla H, Splaingard M. Sleep problems in children with common medical disorders. Pediatr Clin North Am. 2004;51(1):203-227, viii.
15. Regard L, Lafoeste H, Martin C, Chassagnon G, Burgel PR. [Ageing with cystic fibrosis: Classical and emerging comorbidities in adults with cystic fibrosis]. Rev Pneumol Clin. 2018;74(5):279-291.
16. Litvin M, Yoon JC, Leey Casella J, Blackman SM, Brennan AL. Energy balance and obesity in individuals with cystic fibrosis. J Cyst Fibros. 2019;18 Suppl 2:S38-S47.
17. Harindhanavudhi T, Wang Q, Dunitz J, Moran A, Moheet A. Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis. J Cyst Fibros.2020;19(1):139-145.
18. Hanna RM, Weiner DJ. Overweight and obesity in patients with cystic fibrosis: a center-based analysis. Pediatr Pulmonol.2015;50(1):35-41.
19. Young T, Palta M, Dempsey J, Peppard PE, Nieto FJ, Hla KM. Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ. 2009;108(5):246-249.
20. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing.JAMA. 2000;284(23):3015-3021.
21. Sosnay PR, White TB, Farrell PM, et al. Diagnosis of Cystic Fibrosis in Nonscreened Populations. J Pediatr. 2017;181S:S52-S57 e52.
22. Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation.2008;118(9):955-960.
23. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283(14):1829-1836.
24. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1910-1913.
25. Peltier AC, Consens FB, Sheikh K, Wang L, Song Y, Russell JW. Autonomic dysfunction in obstructive sleep apnea is associated with impaired glucose regulation. Sleep Med. 2007;8(2):149-155.
26. Nap-van der Vlist MM, Burghard M, Hulzebos HJ, et al. Prevalence of severe fatigue among adults with cystic fibrosis: A single center study.J Cyst Fibros. 2018;17(3):368-374.
27. Piper AJ. Sleep and Breathing in Cystic Fibrosis. Totowa, NJ: Humana Press; 2012.
28. Marcus CL, Brooks LJ, Draper KA, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics.2012;130(3):e714-755.
29. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(3):479-504.
30. Berry RB, Brooks R, Gamaldo C, et al. AASM Scoring Manual Updates for 2017 (Version 2.4). J Clin Sleep Med. 2017;13(5):665-666.
31. Douglas NJ, White DP, Pickett CK, Weil JV, Zwillich CW. Respiration during sleep in normal man. Thorax. 1982;37(11):840-844.
32. White JE, Drinnan MJ, Smithson AJ, Griffiths CJ, Gibson GJ. Respiratory muscle activity during rapid eye movement (REM) sleep in patients with chronic obstructive pulmonary disease. Thorax.1995;50(4):376-382.
33. Kirk V, Baughn J, D’Andrea L, et al. American Academy of Sleep Medicine Position Paper for the Use of a Home Sleep Apnea Test for the Diagnosis of OSA in Children. J Clin Sleep Med.2017;13(10):1199-1203.
34. Reiter J, Gileles-Hillel A, Cohen-Cymberknoh M, et al. Sleep disorders in cystic fibrosis: A systematic review and meta-analysis.Sleep Med Rev. 2020;51:101279.
35. Schidlow DV, Taussig LM, Knowles MR. Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis. Pediatr Pulmonol. 1993;15(3):187-198.
36. de Castro-Silva C, de Bruin VM, Cavalcante AG, Bittencourt LR, de Bruin PF. Nocturnal hypoxia and sleep disturbances in cystic fibrosis.Pediatr Pulmonol. 2009;44(11):1143-1150.
37. Fauroux B, Pepin JL, Boelle PY, et al. Sleep quality and nocturnal hypoxaemia and hypercapnia in children and young adults with cystic fibrosis. Arch Dis Child. 2012;97(11):960-966.
38. Frangolias DD, Wilcox PG. Predictability of oxygen desaturation during sleep in patients with cystic fibrosis : clinical, spirometric, and exercise parameters. Chest. 2001;119(2):434-441.
39. Tabeling C, Yu H, Wang L, et al. CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci U S A.2015;112(13):E1614-1623.
40. Macrea MM, Owens RL, Martin T, Smith D, Oursler KK, Malhotra A. The effect of isolated nocturnal oxygen desaturations on serum hs-CRP and IL-6 in patients with chronic obstructive pulmonary disease. Clin Respir J. 2019;13(2):120-124.
41. Isaiah A, Daher A, Sharma PB, Naqvi K, Mitchell RB. Predictors of sleep hypoxemia in children with cystic fibrosis. Pediatr Pulmonol. 2019;54(3):273-279.
42. Gomez Punter RM, Giron Moreno RM, Vazquez Espinosa E, et al. Desaturations During 6-Minute Walk Test and Predicting Nocturnal Desaturations in Adult Subjects With Cystic Fibrosis. Respir Care. 2019;64(1):48-54.
43. Allen MB, Mellon AF, Simmonds EJ, Page RL, Littlewood JM. Changes in nocturnal oximetry after treatment of exacerbations in cystic fibrosis.Arch Dis Child. 1993;69(2):197-201.
44. Salvatore D, D’Andria M. Effects of salmeterol on arterial oxyhemoglobin saturations in patients with cystic fibrosis.Pediatr Pulmonol. 2002;34(1):11-15.
45. Gozal D. Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen. Eur Respir J.1997;10(9):1999-2003.
46. Elphick HE, Mallory G. Oxygen therapy for cystic fibrosis.Cochrane Database Syst Rev. 2013(7):CD003884.
47. Ramos RT, Salles C, Gregorio PB, et al. Evaluation of the upper airway in children and adolescents with cystic fibrosis and obstructive sleep apnea syndrome. Int J Pediatr Otorhinolaryngol.2009;73(12):1780-1785.
48. Villa MP, Pagani J, Lucidi V, Palamides S, Ronchetti R. Nocturnal oximetry in infants with cystic fibrosis. Arch Dis Child.2001;84(1):50-54.
49. Jiang RS, Liang KL, Hsin CH, Su MC. The impact of chronic rhinosinusitis on sleep-disordered breathing. Rhinology.2016;54(1):75-79.
50. Alt JA, DeConde AS, Mace JC, Steele TO, Orlandi RR, Smith TL. Quality of Life in Patients With Chronic Rhinosinusitis and Sleep Dysfunction Undergoing Endoscopic Sinus Surgery: A Pilot Investigation of Comorbid Obstructive Sleep Apnea. JAMA Otolaryngol Head Neck Surg. 2015;141(10):873-881.
51. Mahdavinia M, Schleimer RP, Keshavarzian A. Sleep disruption in chronic rhinosinusitis. Expert Rev Anti Infect Ther.2017;15(5):457-465.
52. Mahdavinia M, Hui JW, Zitun M, et al. Patients with chronic rhinosinusitis and obstructive sleep apnea have increased paroxysmal limb movement. Am J Rhinol Allergy. 2018;32(2):94-97.
53. Alt JA, Smith TL. Chronic rhinosinusitis and sleep: a contemporary review. Int Forum Allergy Rhinol. 2013;3(11):941-949.
54. Henderson RC, Specter BB. Kyphosis and fractures in children and young adults with cystic fibrosis. J Pediatr.1994;125(2):208-212.
55. Troosters T, Langer D, Vrijsen B, et al. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis.Eur Respir J. 2009;33(1):99-106.
56. Shook JE, Watkins WD, Camporesi EM. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. Am Rev Respir Dis. 1990;142(4):895-909.
57. Milross MA, Piper AJ, Dwyer TJ, et al. Non-invasive ventilation versus oxygen therapy in cystic fibrosis: A 12-month randomized trial.Respirology. 2019;24(12):1191-1197.
58. de Felicio CM, da Silva Dias FV, Trawitzki LVV. Obstructive sleep apnea: focus on myofunctional therapy. Nat Sci Sleep.2018;10:271-286.
59. Fleury Curado T, Oliven A, Sennes LU, Polotsky VY, Eisele D, Schwartz AR. Neurostimulation Treatment of OSA. Chest.2018;154(6):1435-1447.
60. Sarkissian L, Kitipornchai L, Cistulli P, Mackay SG. An update on the current management of adult obstructive sleep apnoea. Aust J Gen Pract. 2019;48(4):182-186.
61. Kuhle S, Urschitz MS. Anti-inflammatory medications for obstructive sleep apnea in children. Cochrane Database Syst Rev.2011(1):CD007074.
62. Smith DF, Sarber KM, Spiceland CP, Ishman SL, Augelli DM, Romaker AM. Effects of Medical Therapy on Mild Obstructive Sleep Apnea in Adult Patients. J Clin Sleep Med. 2019;15(7):979-983.
63. Zinman R, Corey M, Coates AL, et al. Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients. J Pediatr.1989;114(3):368-377.
64. Young AC, Wilson JW, Kotsimbos TC, Naughton MT. Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis. Thorax. 2008;63(1):72-77.
65. Moran F, Bradley JM, Piper AJ. Non-invasive ventilation for cystic fibrosis. Cochrane Database Syst Rev. 2017;2:CD002769.
66. Stanford G, Parrott H, Bilton D, Agent P. Positive pressure–analysing the effect of the addition of non-invasive ventilation (NIV) to home airway clearance techniques (ACT) in adult cystic fibrosis (CF) patients. Physiother Theory Pract.2015;31(4):270-274.
67. Rodriguez Hortal MC, Nygren-Bonnier M, Hjelte L. Non-invasive Ventilation as Airway Clearance Technique in Cystic Fibrosis.Physiother Res Int. 2017;22(3).
68. Valipour A, Makker HK, Hardy R, Emegbo S, Toma T, Spiro SG. Symptomatic gastroesophageal reflux in subjects with a breathing sleep disorder. Chest. 2002;121(6):1748-1753.
69. Irwin MR. Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol. 2015;66:143-172.
70. Park H, Tsai KM, Dahl RE, et al. Sleep and Inflammation During Adolescence. Psychosom Med. 2016;78(6):677-685.
71. Fernandez-Mendoza J, Baker JH, Vgontzas AN, Gaines J, Liao D, Bixler EO. Insomnia symptoms with objective short sleep duration are associated with systemic inflammation in adolescents. Brain Behav Immun.2017;61:110-116.
72. Kong AP, Wing YK, Choi KC, et al. Associations of sleep duration with obesity and serum lipid profile in children and adolescents.Sleep Med. 2011;12(7):659-665.
73. Bonuck K, Chervin RD, Howe LD. Sleep-disordered breathing, sleep duration, and childhood overweight: a longitudinal cohort study. J Pediatr. 2015;166(3):632-639.
74. Koren D, Gozal D, Philby MF, Bhattacharjee R, Kheirandish-Gozal L. Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children. Eur Respir J. 2016;47(4):1152-1161.
75. Rudnicka AR, Nightingale CM, Donin AS, et al. Sleep Duration and Risk of Type 2 Diabetes. Pediatrics. 2017;140(3).
76. Voynow JA MM, Kelly A, Scanlin TF. Cystic Fibrosis. Vol Chapter 50, Volume 1. 5th Edition ed: McGraw Hill; 2015.
The authors thank Dr. Thomas Scanlin M.D. and Dr. Nisha Aurora M.D. for their review of the paper and valuable suggestions. The authors also thank the Cystic Fibrosis Foundation for the grant support of the Rutgers-Robert Wood Johnson Medical School pediatric and adult Cystic Fibrosis programs (CC 154).